New England J Med 381(9):84151 Mansoor H, L BA, Morten D, Kathleen D, G EF, R FD et al (2019) Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes
10.1016/0168-9452(90)90207-5 19 HwangC
Moreover, AEP obviously increased adenosine monophosphate-activated protein kinase (p-AMPK/AMPK), and exhibited anti-apoptotic effects by diminishing the levels of cleaved caspase-3, and bcl-2-associated X protein (Bax), and enhanced Bcl-2 expression in the same models (Liao et al., 2019b)
less water means a more concentrated solution and a smaller draw
[1] [2] The overall cardiovascular and metabolic benefits of GLP-1 therapy often outweigh potential risks when appropriate monitoring is in place